Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-010889
Filing Date
2026-01-12
Accepted
2026-01-12 21:32:13
Documents
1
Period of Report
2026-01-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5279
  Complete submission text file 0001193125-26-010889.txt   6655
Mailing Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065 240-327-0603
Arcellx, Inc. (Issuer) CIK: 0001786205 (see all company filings)

EIN.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 407 WATTS STREET DURHAM NC 27701
Business Address
Heery Christopher (Reporting) CIK: 0001789632 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41259 | Film No.: 26528290